Can A Simple Blood Test Really Spot Cancer Early? Don’t Bet On It Yet, Scientists Say. External Web Site Icon SM Lee, Buzzfeed, April 13, 2017

https://phgkb.cdc.gov/GAPPKB/phgHome.do






Last Posted: Apr 12, 2017

---

• Can A Simple Blood Test Really Spot Cancer Early? Don’t Bet On It Yet, Scientists Say.  
  SM Lee, Buzzfeed, April 13, 2017
• New blood test could help detect and locate cancer early on  
  Science Magazine, March 6, 2017
• New ‘blood biopsies’ with experimental device may improve cancer diagnosis and follow-up  
  Science Magazine, February 13, 2017
• Grail to pour $1 billion into blood test to detect early cancer  
  C Sheridan, Nat Biotechnology, February 7, 2017
• Circulating Tumor DNA May Serve as a Prognostic Marker in Pancreatic Cancer  
  J Cavallo, ASCO Post, December 20, 2016
• Circulating tumor DNA technology: the future of cancer management?  
  L Blackburn, PHG Foundation, December 20, 2016
• Exploratory Analysis of TP53 Mutations in Circulating Tumour DNA as Biomarkers of Treatment Response for Patients with Relapsed High-Grade Serous Ovarian Carcinoma: A Retrospective Study  
  CA Parkinson et al, PLOS Medicine, December 20, 2016
• KRAS mutations in the circulating free DNA (cfDNA) of non-small cell lung cancer (NSCLC) patients.  
  Garzón Mónica et al. Translational lung cancer research 2016 Oct 5(5) 511-516
• Technological considerations for genome-guided diagnosis and management of cancer.  
  Lennon Niall J et al. Genome medicine 2016 Oct 8(1) 112
• Clinical Utility of Circulating Tumor DNA for Molecular Assessment and Precision Medicine in Pancreatic Cancer.  
  Takai Erina et al. Advances in experimental medicine and biology 2016 92413-17
• The Role of Genomic Profiling in Advanced Breast Cancer: The Two Faces of Janus.  
  Eralp Yesim et al. Translational oncogenomics 2016 8(Suppl 1) 1-7
• ESR1 Mutations in Cell-Free DNA of Breast Cancer Predictive “Tip of the Iceberg"  
  Suzanne A. W. Fuqua et al, JAMA Oncology, August 11, 2016
• Prevalence of ESR1 Mutations in Cell-Free DNA and Outcomes in Metastatic Breast Cancer A Secondary Analysis of the BOLERO-2 Clinical Trial  
  Sarat Chandarlapaty, et al, JAMA Oncology, August 11, 2016
• The Holy Grail of Liquid Biopsies  
  Genome Magazine, June 23, 2016
• Blood Test for Genetic Changes in Tumors Shows Promise as Alternative to Tumor Biopsy  
  NCI, June 14, 2016
• ‘Liquid biopsy’ study offers hope for a blood test to find cancer  
  L McGinley, Washington Post, June 4, 2016

more